Porton Advanced is a Cell and Gene Therapy (CGT) CDMO/CRO. We provide end-to-end research grade, process development (PD), analytical development (AD), GMP manufacturing, and testing services of AAV, Lentivirus, mRNA, and plasmid to meet clients’ therapeutic product needs at pre-clinical, clinical, and commercial stages.

Our dedicated process and analytical development teams have established robust platform-based USP/DSP and GMP manufacturing capability and capacity, as well as proprietary technologies to further empower our clients’ successes.

Our services include gene and cell engineering discovery research and technology licensing, process development and analytical development, testing, drug substances (DS) and drug products (DP), and cGMP manufacturing across plasmids, cell therapy, gene therapy, virotherapy, and mRNA-based therapeutic platforms. 

Contact us
Business inquiry and collaboration
Email: info@portonadvanced.com

Visit our website to find out how Porton Advanced help sponsors to advance their programs.

Biotechnology

Clinical Trials

Life Sciences

Therapeutics

Porton Advanced │ Cell & Gene Therapy CDMO/CRO

Porton Advanced │ Cell & Gene Therapy CDMO/CRO's headquarters in Cranbury, NJ, United States

Description

People

Jobs